Synopsis
0
EU WC
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 160MG/100ML
USFDA APPLICATION NUMBER - 18132
DOSAGE - INJECTABLE;INJECTION - 40MG/ML
USFDA APPLICATION NUMBER - 18132
DOSAGE - INJECTABLE;INJECTION - 80MG/100ML
USFDA APPLICATION NUMBER - 18132
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Coating Systems & Additives
Controlled & Modified Release
Fillers, Diluents & Binders
Topical
Thickeners and Stabilizers
Taste Masking
Film Formers & Plasticizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
72
PharmaCompass offers a list of Dopamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dopamine manufacturer or Dopamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dopamine manufacturer or Dopamine supplier.
PharmaCompass also assists you with knowing the Dopamine API Price utilized in the formulation of products. Dopamine API Price is not always fixed or binding as the Dopamine Price is obtained through a variety of data sources. The Dopamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dopamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dopamine, including repackagers and relabelers. The FDA regulates Dopamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dopamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dopamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dopamine supplier is an individual or a company that provides Dopamine active pharmaceutical ingredient (API) or Dopamine finished formulations upon request. The Dopamine suppliers may include Dopamine API manufacturers, exporters, distributors and traders.
click here to find a list of Dopamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dopamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Dopamine active pharmaceutical ingredient (API) in detail. Different forms of Dopamine DMFs exist exist since differing nations have different regulations, such as Dopamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dopamine DMF submitted to regulatory agencies in the US is known as a USDMF. Dopamine USDMF includes data on Dopamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dopamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dopamine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dopamine Drug Master File in Japan (Dopamine JDMF) empowers Dopamine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dopamine JDMF during the approval evaluation for pharmaceutical products. At the time of Dopamine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dopamine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dopamine Drug Master File in Korea (Dopamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dopamine. The MFDS reviews the Dopamine KDMF as part of the drug registration process and uses the information provided in the Dopamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dopamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dopamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dopamine suppliers with KDMF on PharmaCompass.
A Dopamine CEP of the European Pharmacopoeia monograph is often referred to as a Dopamine Certificate of Suitability (COS). The purpose of a Dopamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dopamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dopamine to their clients by showing that a Dopamine CEP has been issued for it. The manufacturer submits a Dopamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dopamine CEP holder for the record. Additionally, the data presented in the Dopamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dopamine DMF.
A Dopamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dopamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dopamine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dopamine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dopamine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dopamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dopamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dopamine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dopamine suppliers with NDC on PharmaCompass.
Dopamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dopamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dopamine GMP manufacturer or Dopamine GMP API supplier for your needs.
A Dopamine CoA (Certificate of Analysis) is a formal document that attests to Dopamine's compliance with Dopamine specifications and serves as a tool for batch-level quality control.
Dopamine CoA mostly includes findings from lab analyses of a specific batch. For each Dopamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dopamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dopamine EP), Dopamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dopamine USP).
